QKY-613 is a prodrug that augments immune surveillance by promoting 6mdA integration into viral DNA, enhancing cGAS activation via DNA phase separation. It has demonstrated efficacy in reducing mortality in aged mouse models of viral infection, making it a valuable tool for studying immunology and nucleic acid modification pathways.
Molekulargewicht:
582.55
CAS Nummer:
[2484713-92-8]
Formel:
C27H31N6O7P
Target-Kategorie:
cGAS,Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten